Castle Biosciences to Participate in Upcoming Investor Conferences

Company Overview - Castle Biosciences, Inc. is scheduled to present a company overview at Baird's 2025 Global Healthcare Conference on September 10, 2025, at 10:15 a.m. Eastern time [1] - The company is a leading diagnostics firm focused on improving health through innovative tests that guide patient care [4] Upcoming Events - A live audio webcast of the company's presentation will be available on its website, with a replay accessible after the live broadcast [2] - Castle will participate in one-on-one investor meetings during the Wells Fargo 20th Annual Healthcare Conference on September 4, 2025, and the 9th Annual Lake Street Best Ideas Growth Conference on September 11, 2025 [3] Product Portfolio - Castle's current portfolio includes tests for skin cancers, Barrett's esophagus, and uveal melanoma [5] - The company is engaged in research and development for additional tests, including one aimed at guiding systemic therapy selection for patients with moderate-to-severe atopic dermatitis seeking biologic treatment [5]